678992-82-0 Usage
Chemical structure
The compound consists of a benzene ring with two cyano groups attached to it, a pyrazole ring connected to an ethyl group and a phenoxyethyl group, and a methylsulfonyl group attached to the phenoxy group.
Molecular weight
Approximately 351.4 g/mol
Appearance
The compound is likely to be a solid or a viscous liquid, although the exact physical state is not specified in the provided material.
Solubility
The solubility of the compound is not explicitly mentioned in the material, but it is likely to be soluble in organic solvents such as ethanol, methanol, or acetone due to its nonpolar nature.
Stability
The stability of the compound is not specified in the material, but it is generally expected to be stable under normal conditions, such as room temperature and pressure.
Reactivity
The compound may react with strong acids, bases, or nucleophiles due to the presence of the cyano, pyrazole, and phenoxy groups in its structure.
Potential applications
The compound has a variety of potential uses and applications, including in pharmaceuticals, agrochemicals, and materials science, due to its diverse structure and properties.
Synthesis
The synthesis of the compound is not described in the provided material, but it likely involves multiple steps, including the formation of the benzene ring, the attachment of the cyano groups, and the formation of the pyrazole and phenoxyethyl groups.
Safety precautions
The safety precautions for handling and using 1,3-Benzenedicarbonitrile,
5-[[3-ethyl-5-[2-[4-(methylsulfonyl)phenoxy]ethyl]-1H-pyrazol-4-yl]oxy]- are not specified in the material, but it is generally recommended to follow standard laboratory safety practices, such as wearing gloves, goggles, and a lab coat, and working in a well-ventilated area or fume hood.
Check Digit Verification of cas no
The CAS Registry Mumber 678992-82-0 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 6,7,8,9,9 and 2 respectively; the second part has 2 digits, 8 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 678992-82:
(8*6)+(7*7)+(6*8)+(5*9)+(4*9)+(3*2)+(2*8)+(1*2)=250
250 % 10 = 0
So 678992-82-0 is a valid CAS Registry Number.
678992-82-0Relevant academic research and scientific papers
Pyrazole derivatives
-
Page/Page column 10, (2010/02/11)
This invention relates to pyrazole derivatives of formula (I) or pharmaceutically acceptable salts, solvates or derivative thereof, wherein R1 to R4 are defined in the description, and to processes for the preparation thereof, intermediates used in their preparation of, compositions containing them and the uses of such derivatives. The compounds of the present invention bind to the enzyme reverse transcriptase and are modulators, especially inhibitors thereof. As such the compounds of the present invention are useful in the treatment of a variety of disorders including those in which the inhibition of reverse transcriptase is implicated. Disorders of interest include those caused by Human Immunodificiency Virus (HIV) and genetically related retroviruses, such as Acquired Immune Deficiency Syndrome (AIDS).
PYRAZOLE DERIVATIVES AND THEIR USE AS THERAPEUTIC AGENTS FOR HIV MEDIATED DISEASES
-
Page 24, (2008/06/13)
This invention relates to pyrazole derivatives of formula (I)or pharmaceutically acceptable salts, solvates or derivative thereof, wherein R' to R4; ;ark defined in the description, and to processes for the preparation thereof, intermediates used in their preparation of, compositions containing them and the uses of such derivatives. The compounds of the present invention bind to the enzyme reverse transcriptase and are modulators, especially inhibitors thereof. As such the compounds of the present invention are useful in the treatment of a variety of disorders including those in which the inhibition' of reverse transcriptase is implicated. Disorders of interest include those caused by Human Immunodificiency Virus (HIV) and genetically related retroviruses, such as Acquired Immune Deficiency Syndrome (AIDS).